3BNC117 and 10-1074 in ART-treated Individuals

NCT03526848 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: 3BNC117
DRUG: 10-1074
OTHER: Analytical treatment interruption

Sponsor

Rockefeller University

Collaborators

[object Object]
[object Object]
[object Object]